Protocol M13-590: A Randomized, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults with Chronic Hepatitis C Virus Genotype 1 Infection (ENDURANCE-1)

Project: Research project

Project Details

StatusFinished
Effective start/end date1/18/161/18/19

Funding

  • AbbVie Inc. (Protocol M13-590)